India will sign a comprehensive umbrella science and technology agreement with the United States in October, said Union science and technology & ocean development minister Kapil Sibal. |
Speaking at a seminar on 'Science and Technology Opportunities and Indo-US Relations', organised by Observer Research Foundation in Bangalore on Friday, Sibal said: "This agreement has been in the works for the last 10 years and we have now sorted out all issues and we should be signing this in October." |
He said that US' decision to go slow on supporting India on the fields of bio-technology and nano-technology was a stumbling block and this has been sorted out. |
"They were looking forward to India's support in low-cost nuclear technology issues but were not reciprocating on BT and nano-tech issues. I have personally intervened and hopefully this landmark agreement will settle all IP related issues," Sibal said and added this is a great step forward. |
Sibal further highlighted that with this agreement, India has the potential to be a manufacturing hub for the pharma industry, especially in vaccines, as "we are a low-cost economy with high quality human resources... I have had scores of discussion with MNCs in the pharmaceutical sector and they all agree that to reduce the cost of bringing out a drug, it is imperative to have an India manufacturing centre. There is no other choice for global firms as the combination of top-class HR with economies of scale are not available easily." |
Sibal also noted that he is pushing for setting up of a Federal Drug Administration (FDA) sort of body in India, inculcating world-class systems and processes of FDA. |
"If we get such a world-class certifying process in India, the issue of going in for repeated trials in each of the countries by a firm to market its drugs will be eliminated. The Indian Health Ministry is working out the framework and we will engage FDA to share their best practices," Sibal added. |